Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

624 Articles

Chris Lange | Jan 25, 2018 at 10:10 AM EST

Major Pharma Short Interest Keeps Climbing

The January 12 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jan 25, 2018 at 10:00 AM EST

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

With the market trading at very extended valuations, and the S&P 500 on the longest streak ever without a 5%…

Jon C. Ogg | Jan 22, 2018 at 9:14 AM EST

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger, Verizon and More

The top analyst upgrades, downgrades and other research calls from Monday include Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton,…

Jon C. Ogg | Jan 16, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Amazon.com, Boeing, Chesapeake Energy, Eli Lilly, Gilead Sciences,…

Chris Lange | Jan 11, 2018 at 9:45 AM EST

Major Pharma Short Interest Takes a Plunge

The December 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 6, 2018 at 8:55 AM EST

20 More Biopharma Catalysts Coming in 2018

Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves…

Jon C. Ogg | Jan 5, 2018 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva, Tyson, Walgreens and More

The top analyst upgrades, downgrades and other research calls from Friday include Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite…

Chris Lange | Dec 28, 2017 at 10:25 AM EST

More and More Short Sellers Raising the Stakes in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Dec 12, 2017 at 10:40 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Nov 10, 2017 at 11:25 AM EST

Short Sellers Back Way Off Major Pharma

The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Oct 25, 2017 at 10:20 AM EDT

Short Sellers Hike Bets in Major Pharma

The October 13 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Oct 24, 2017 at 12:25 PM EDT

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Lee Jackson | Oct 19, 2017 at 8:30 AM EDT

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

These four top companies all have data that could move the shares the rest of this year and into 2018.…

Jon C. Ogg | Oct 18, 2017 at 2:10 PM EDT

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

With Eli Lilly making a huge headline investment in a cancer vaccine, 24/7 Wall St. wanted to look under the…

1 … 20 21 22 23 24 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Major Pharma Short Interest Keeps Climbing

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger, Verizon and More

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Top Analyst Upgrades and Downgrades: Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva, Tyson, Walgreens and More

More and More Short Sellers Raising the Stakes in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Back Way Off Major Pharma

Short Sellers Hike Bets in Major Pharma

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Fastenal (FAST): The Quiet Compounder Nobody Talks About Is a Buy-and-Hold-Forever Stock

Beyond SpaceX — Firefly Is the Space Stock You Can Actually Buy Today

2 Top AI Stocks To Put On Your Shortlist

Here Is What I Would Tell a Tech Founder Heading Into a Tax-Free Decade of Early Retirement

How Much Do You Really Need Invested to Replace an $80,000 Salary With Dividends?

Fastenal (FAST): The Quiet Compounder Nobody Talks About Is a Buy-and-Hold-Forever Stock

Beyond SpaceX — Firefly Is the Space Stock You Can Actually Buy Today

Eli Lilly : LLY

All Eli Lilly Articles

Major Pharma Short Interest Keeps Climbing

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger, Verizon and More

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Top Analyst Upgrades and Downgrades: Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva, Tyson, Walgreens and More

More and More Short Sellers Raising the Stakes in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

Short Sellers Back Way Off Major Pharma

Short Sellers Hike Bets in Major Pharma

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Fastenal (FAST): The Quiet Compounder Nobody Talks About Is a Buy-and-Hold-Forever Stock

Beyond SpaceX — Firefly Is the Space Stock You Can Actually Buy Today

2 Top AI Stocks To Put On Your Shortlist

Featured Reads

Here Is What I Would Tell a Tech Founder Heading Into a Tax-Free Decade of Early Retirement

How Much Do You Really Need Invested to Replace an $80,000 Salary With Dividends?